Our Pricing

Mounjaro Maintenance Dose - Prescription Weight Loss UK

Understanding your mounjaro maintenance dose uk schedule is essential for achieving sustained weight loss results. At Cured Pharmacy, our UK-registered prescribers assess your individual response to tirzepatide and determine the optimal maintenance dose—whether 5mg, 10mg, or 15mg—to maximise long-term outcomes whilst minimising side effects.

Understanding Mounjaro Maintenance Dose Protocols

Mounjaro (tirzepatide) follows a structured dose escalation protocol designed to optimise tolerability whilst achieving therapeutic effect [1]. Unlike treatments that start at a fixed dose, tirzepatide begins at 2.5mg weekly for four weeks, then increases by 2.5mg increments every four weeks until your maintenance dose is reached.

The maintenance dose is the level at which you achieve optimal weight loss with acceptable side effects—typically between 5mg and 15mg weekly [1]. In the SURPASS-1 trial, patients on the 15mg maintenance dose achieved an average 9.5kg weight reduction over 40 weeks, whilst those on 10mg lost an average 8.4kg [2]. Your UK prescriber will determine your ideal maintenance dose based on your weight loss progress, tolerability, and clinical response during the escalation phase.

Most patients reach their maintenance dose between weeks 8 and 20 of treatment. Once established, this dose continues indefinitely as part of long-term weight management, subject to ongoing prescriber review every 12 weeks.

Mounjaro Dose Escalation Schedule Explained

The standard Mounjaro dose escalation follows a gradual four-week increment protocol approved by the MHRA for UK use [1]. This systematic approach allows your body to adapt to increasing GIP and GLP-1 receptor activation, significantly reducing the gastrointestinal side effects common with faster titration schedules.

Week 1-4: 2.5mg once weekly (starter dose). Week 5-8: 5mg once weekly. Week 9-12: 7.5mg once weekly. Week 13-16: 10mg once weekly. Week 17-20: 12.5mg once weekly. Week 21+: 15mg once weekly (maximum licensed dose) [1].

Your prescriber may pause escalation at any stage if you're achieving satisfactory weight loss or experiencing side effects. Clinical trials demonstrated that patients who maintained slower escalation schedules reported 40% fewer gastrointestinal adverse events compared to accelerated protocols [2].

When to Stop Dose Escalation

Not every patient requires the maximum 15mg dose. NICE guidance suggests maintaining your current dose if you've achieved at least 5% body weight reduction and tolerate the medication well [3]. Your UK prescriber will assess whether further escalation offers meaningful additional benefit or whether your current dose represents your optimal maintenance level.

Some patients achieve their target weight loss on 5mg or 7.5mg weekly and remain at that maintenance dose long-term. There's no clinical requirement to reach the maximum dose—the goal is finding your individual therapeutic threshold.

Comparing Mounjaro Maintenance Doses: 5mg vs 10mg vs 15mg

Each Mounjaro maintenance dose tier offers distinct efficacy profiles based on clinical trial data. In the SURPASS-3 study comparing tirzepatide doses head-to-head, the 5mg maintenance dose produced an average 15.0% total body weight reduction over 72 weeks, whilst 10mg achieved 19.5%, and 15mg reached 22.5% [4].

The 5mg maintenance dose suits patients who achieve early satisfactory weight loss or experience persistent nausea at higher doses. This dose still significantly outperforms older weight loss medications—clinical trials showed 5mg tirzepatide produced greater weight reduction than 1mg semaglutide [4].

The 10mg maintenance dose represents the middle tier and is often the optimal balance between efficacy and tolerability for many UK patients. Approximately 60% of patients in clinical trials maintained this dose long-term [2]. The 15mg maintenance dose is reserved for patients who tolerate escalation well and require maximum therapeutic effect—typically those with BMI above 35 or significant obesity-related comorbidities.

How Long to Stay on Mounjaro Maintenance Dose

Mounjaro is licensed for long-term weight management, meaning your maintenance dose continues as an ongoing treatment rather than a fixed-duration course [1]. Clinical trials followed patients for up to 72 weeks on maintenance doses, demonstrating sustained weight loss without plateau when treatment continued [4].

Weight regain commonly occurs when tirzepatide is discontinued. A 2023 study published in Diabetes, Obesity and Metabolism found that patients who stopped Mounjaro after reaching their target weight regained an average 14% of lost weight within 17 weeks of cessation [5]. This underscores the medication's role as a long-term management tool rather than a short-term intervention.

Your UK prescriber will review your maintenance dose every 12 weeks to assess ongoing clinical benefit, tolerability, and appropriateness of continued treatment. Some patients may reduce their maintenance dose after prolonged weight stability, though this requires careful prescriber supervision to prevent rebound weight gain.

Adjusting Your Maintenance Dose Over Time

Maintenance doses aren't necessarily permanent. If you experience prolonged side effects, your prescriber may reduce your dose by one tier (e.g., from 10mg to 7.5mg) and monitor whether weight loss continues at the lower level. Conversely, if weight loss plateaus despite lifestyle adherence, dose escalation to the next tier may be considered.

Dose adjustments should only occur under prescriber guidance. Self-adjusting your Mounjaro dose can compromise efficacy and increase side effect risk.

Managing Side Effects on Your Mounjaro Maintenance Dose

Gastrointestinal side effects—particularly nausea, diarrhoea, and constipation—are most common during dose escalation but typically diminish once your maintenance dose stabilises [1]. In clinical trials, 80% of patients reporting nausea experienced symptom resolution within four weeks of maintaining a stable dose [2].

If side effects persist on your maintenance dose, several strategies can help. Taking your injection on the same day each week, staying well-hydrated, eating smaller frequent meals, and avoiding high-fat foods can significantly reduce gastrointestinal symptoms. Your prescriber may also recommend temporarily reducing your dose by one tier to reassess tolerance.

Serious side effects are rare but require immediate medical attention. These include severe abdominal pain (potential pancreatitis), persistent vomiting preventing fluid intake, vision changes, or signs of thyroid nodules [1]. Contact your prescriber or NHS 111 if you experience any concerning symptoms whilst on your maintenance dose.

Accessing Mounjaro Maintenance Doses Through Cured Pharmacy

Cured Pharmacy provides all Mounjaro maintenance doses—2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg KwikPens—with transparent upfront pricing from £135.00. Our UK-registered prescribers conduct thorough clinical assessments to determine your appropriate starting dose and create a personalised escalation schedule tailored to your weight loss goals and medical history.

Every Mounjaro prescription includes ongoing prescriber support throughout your dose escalation and maintenance phases. We schedule 12-week reviews to assess your progress, adjust dosing as needed, and ensure you're achieving optimal outcomes safely. All medications are genuine UK-licensed products dispensed by our GPhC-registered pharmacy team led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073).

Your free online consultation takes under three minutes and includes a comprehensive assessment of your BMI, weight loss history, current medications, and contraindications. If Mounjaro is clinically appropriate, your prescription is processed the same day with discreet next-day delivery available across the UK.

Prescription Requirements for Mounjaro Maintenance Doses

All Mounjaro doses require a valid UK prescription issued by a registered prescriber. You cannot purchase tirzepatide over the counter or transfer prescriptions from non-UK providers. Our clinical team assesses each patient individually—Mounjaro is typically prescribed for adults with BMI ≥30 kg/m², or ≥27 kg/m² with weight-related comorbidities, in line with NICE guidance [3].

Prescriptions are issued for 12-week supplies and require clinical review before renewal. This ensures your maintenance dose remains appropriate and allows dose adjustments based on your ongoing response to treatment.

Scientific References

1. Electronic Medicines Compendium. (2024). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14297
2. Rosenstock, J., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155. https://doi.org/10.1016/S0140-6736(21)01324-6
3. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating overweight and obesity [TA1003]. NICE. Retrieved from https://www.nice.org.uk/guidance/ta1003
4. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216. https://doi.org/10.1056/NEJMoa2206038
5. Aronne, L. J., et al. (2023). Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA, 331(1), 38-48. https://doi.org/10.1001/jama.2023.24945

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.